Tamim Niazi
Jewish General Hospital · Jewish General Hospital and McGill University · The Jewish General Hospital, Montreal, QC Canada
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tamim Niazi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:47 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06855589 · Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.Charles LeMoyne Hospital · not yet recruiting · Prostate Cancer (Adenocarcinoma) · principal investigator
- Ph3NCT04136353 · Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the ProstateUniversity of Sydney · active not recruiting · Prostate Cancer · study chair
- Ph2NCT04070209 · Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)Sir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Metastatic Prostate Cancer, Castration-resistant Prostate Cancer · principal investigator
- N/ANCT03784755 · Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate CancerCanadian Cancer Trials Group · active not recruiting · Prostate Cancer Metastatic · study chair
- Ph2NCT03763851 · Cannabis Oil and Radiation Therapy for the Management of PainTetra Bio-Pharma · terminated · Metastatic Prostate Cancer, Lung Cancer, Breast Cancer · principal investigator
- Ph2/Ph3NCT02685397 · Management of Castration-Resistant Prostate Cancer with OligometastasesSir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Castration-resistant Prostate Cancer Patients with Oligometastases · principal investigator
- Ph3NCT02303327 · Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer PatientsSir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Prostate Cancer · principal investigator
- Ph3NCT02220829 · Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation TherapySir Mortimer B. Davis - Jewish General Hospital · completed · Urinary Problems, Prostate Cancer · principal investigator
- Ph3NCT01444820 · Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the ProstateSir Mortimer B. Davis - Jewish General Hospital · active not recruiting · Prostate Cancer · principal investigator
- N/ANCT01350180 · Assessing DNA Changes in High Risk Prostate Cancer to Determine PrognosisDr. Tamim Niazi · withdrawn · Prostate Cancer · principal investigator
- Ph2NCT01255891 · Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma ProstateDr. Tamim Niazi · completed · Adenocarcinoma of the Prostate · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:47 UTC. The ranking covers the 200 most relevant of 13 PubMed records, and a shared surname and initials can bring in a namesake. All 13 on PubMed
- 114 citationsRCR 6.1
- 26 citationsRCR 4.6
- Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study.Int J Radiat Oncol Biol Phys · 201225 citationsRCR 1.1
- Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial.Int J Radiat Oncol Biol Phys · 202418 citationsRCR 2.0
- 10 citationsRCR 2.9
- Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786).Clin Oncol (R Coll Radiol) · 20189 citationsRCR 0.4
- The value of Botox-A in acute radiation proctitis: results from a phase I/II study using a three-dimensional scoring system.Int J Radiat Oncol Biol Phys · 20118 citationsRCR 0.3
- Decompression with or without Duraplasty for Chiari I and Syringomyelia.N Engl J Med · 2026
- Does Interfraction Cone Beam Computed Tomography Improve Target Localization in Prostate Bed Radiotherapy?Technol Cancer Res Treat · 20193 citationsRCR 0.2
- 2 citationsRCR 0.6